| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9378(99)70216-4 |
| P698 | PubMed publication ID | 9988803 |
| P2093 | author name string | G A Dekker | |
| J van Eyck | |||
| A C Bolte | |||
| H P van Geijn | |||
| H W Bruinse | |||
| H H Kanhai | |||
| P2860 | cites work | The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? | Q33404012 |
| Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy | Q33484095 | ||
| Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome) | Q34344424 | ||
| Current topic: pre-eclampsia and the placenta | Q37492460 | ||
| Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives | Q41084946 | ||
| Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases | Q43410148 | ||
| Temporising management of severe pre-eclampsia with and without the HELLP syndrome | Q46362894 | ||
| Management of severe, early pre-eclampsia: is conservative management justified? | Q46365335 | ||
| Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy. | Q51752415 | ||
| National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy | Q67266101 | ||
| Intrapartum treatment of preeclamptic hypertension by ketanserin | Q70008795 | ||
| Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist | Q70366430 | ||
| Novel appearance of placental nuclear monoamine oxidase: biochemical and histochemical evidence for hyperserotonomic state in preeclampsia-eclampsia | Q71955318 | ||
| Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial | Q72204702 | ||
| P433 | issue | 2 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-eclampsia | Q61335 |
| P304 | page(s) | 371-377 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome | |
| P478 | volume | 180 |
| Q34307614 | Calcium channel blockers in the management of preterm labor and hypertension in pregnancy |
| Q46351316 | Differences in management and results in term-delivery in nine European referral hospitals: descriptive study |
| Q24200974 | Drugs for treatment of very high blood pressure during pregnancy |
| Q24244908 | Drugs for treatment of very high blood pressure during pregnancy |
| Q30879667 | Drugs for treatment of very high blood pressure during pregnancy. |
| Q35566921 | Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis |
| Q74299147 | Hypertension in pregnancy: new recommendations for management |
| Q34224924 | Management and monitoring of severe preeclampsia |
| Q34194396 | Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers |
| Q43957480 | The optimal dosage of ketanserin for patients with severe hypertension in pregnancy |
Search more.